1Grunenwald S, Caron P. Adrenocortical carcinomas:therapeu- tic advances in 2011 [ J ]. Ann Endocrinol ( Paris ), 2011,72 ( 1 Suppl) : $8.
2Agnantis N J, Goussia A C, Batistatou A, et al. Tumor mark- ers in cancer patients, an update of their prognostic signifi- cance. Part II [ J ]. In Vivo,2004,18 ( 4 ) :481.
3A1-Saad S, A1-Shibli K, Donnem T, et al. The prognostic im- pact of NF-kappaB p105, vimentin,E-cadherin and Par6 ex- pression in epithelial and stromal compartment in non-small- cell lung cancer[ J]. Br J Cancer,2008,99 (9) :1476.
4Yao X, Wang X, Wang Z, et al. Clinicopathological and prog- nostic significance of epithelial mesenchymal transition-relat- ed protein expression in intrahepatic cholangiocarcinoma [ J]. Onco Targets Ther,2012,5 ( 12 ) :255.
5Liu T, Zhang X, Shang M, et al. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer[ J]. J Surg Onco1,2013,107 (2) : 188.
